Cost of Administering Sipuleucel-T (PROVENGE®) is Now Reimbursable by Medicare
On November 2, 2011, the Centers for Medicare and Medicaid Services (“CMS”) issued a Medicare Learning Network Matters article entitled Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer (“CR 7431”) wherein it “instructs that, effective for services performed on or after June 30, 2011, CMS concludes that the evidence is adequate to support the use […]